Japan's $103 million pot stock hypocrisy unmasked

If you condemn the use of cannabis, should you invest in it? We look at the Japanese government pension fund's pot stock holdings.

| More on:
A male ASX investor wearing glasses and a beanie and denim shirt puts his hand to his chin wondering whether to buy ASX shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're travelling from Canada, Holland, certain US states, or any other parts of the world where recreational cannabis use has been legalised, step carefully if you plan to visit Japan.

Japanese courts continue to enforce strict laws surrounding the use of cannabis, which can see an offender sent to prison for up to 5 years for personal use.

Of more concern to international travellers who may have consumed marijuana in a legal jurisdiction outside Japan, earlier this year, the Japanese government debated making it a crime for people to have THC inside their bloodstream.

Fair warning Tokyo residents, you may want to steer clear of Amsterdam once COVID travel restrictions are lifted.

Japanese government's pot stock hypocrisy

If a national government condemns the use of cannabis, should it invest in pot stocks?

While the principled answer appears to be 'no', that hasn't stopped Japan's Government Pension Investment Fund from snapping up some US$80 million (AU$103 million) worth of shares in 3 cannabis companies trading on Canada's Ontario stock exchange.

As Bloomberg reports:

Financial disclosures show Japan's Government Pension Investment Fund (GPIF) accumulated stakes totaling some $80 million in at least three pot companies.

With 1.7 million shares of Canopy Growth Corp, which trades on the Ontario stock exchange under the ticker WEED, the fund would be among the top 12 holders of the recreational marijuana dealer.

Now granted, US$80 million is just a tiny fraction of the Japanese Government Pension Investment Fund's US$1.6 trillion in assets.

But still.

So why the seeming hypocrisy?

According to the government pension fund's spokeswoman Nao Honda, "We are dedicated solely to ensuring long-term returns for our members."

Gotcha. Show me the money!

Now the Japanese Government Pension Fund hasn't invested in any ASX listed pot stocks. At least not yet. But there are a growing number of them blooming on the ASX. (Sorry, couldn't resist.)

Two leading ASX pot stocks

There are a number of cannabis companies listed on the ASX.

Some are focused on hemp production, which produces no THC. That's the compound in cannabis that gives users the 'high'.

Others are primarily focused on medicinal marijuana, which has the green light in Australia. And still others are involved in the recreational side of cannabis use in the legal markets, such as Canada.

Cann Group Ltd (ASX: CAN), for example, cultivates cannabis for both medicinal and research purposes. At the current price of 59 cents per share, Cann Group has a market cap of $162 million. The Cann Group share price closed at 59 cents today, up 1.72% in intraday trading today and down 1.7% in 2021.

Creso Pharma Ltd (ASX: CPH) develops pharmaceutical-grade cannabis and hemp-based products to treat human and animal health issues. Creso has finished the day's trading at 22 cents per share, giving it a market cap of $215 million. The Creso Pharma share price is down 4% at the time of writing and up 22% year-to-date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A cute young girl with curly hair sips a glass of milk through a straw with a smile on her face.
Broker Notes

Up 37% this year, why Macquarie expects A2 Milk shares to keep outperforming

Macquarie remains bullish on A2 Milk shares heading into 2026. Let’s see why.

Read more »

Woman and man calculating a dividend yield.
Share Market News

Big week for markets: Here's what to watch

Tech earnings, rate speculation, and Aussie inflation data could shake markets this week — but long-term investors should keep their…

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

dissapointed man at falling share price
Share Fallers

Why Boss Energy, Elsight, Pilbara Minerals, and Whitehaven Coal shares are falling today

These shares are starting the week in the red. But why?

Read more »

An older female ASX investor holds a gangster-style fist pump pose showing off gold rings with dollar signs on them.
Broker Notes

Why Macquarie forecasts Northern Star shares are set to surge 55%

Macquarie believes Northern Star shares are well-placed to rocket higher.

Read more »

A group of people gathered around a laptop computer with various expressions of interest, concern and surprise on their faces. All are wearing glasses.
Share Market News

ASX 200 tech stock near record high, is it still a buy?

This company's soaring share price and rising profits are turning heads.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Bellevue Gold, Bubs, Clarity Pharmaceuticals, and Regal Partners shares are rising today

These shares are starting the week on a positive note.

Read more »

Two people lazing in deck chairs on a beautiful sandy beach throw their hands up in the air.
Travel Shares

Guess which ASX All Ords travel stock just rocketed 17% on an earnings upgrade

Investors are piling into the ASX All Ords travel stock today. Here's what's happening.

Read more »